Abstract
N-methyl-D-aspartate (NMDA) receptor plays important roles in learning and memory. NMDA receptors are a tetramer that consists of two glycine-binding subunits GluN1, two glutamate-binding subunits (i.e., GluN2A, GluN2B, GluN2C, and GluN2D), a combination of a GluN2 subunit and glycine-binding GluN3 subunit (i.e., GluN3A or GluN3B), or two GluN3 subunits. Recent studies revealed that the specific expression and distribution of each subunit are deeply involved in neural excitability, plasticity, and synaptic deficits. The present article summarizes reports on the dysfunction of NMDA receptors and responsible subunits in various neurological and psychiatric disorders, including schizophrenia, autoimmune-induced glutamatergic receptor dysfunction, mood disorders, and autism. A key role for the GluN2D subunit in NMDA receptor antagonist-induced psychosis has been recently revealed.
Keywords: GluN1, GluN2D, knockout mice, NMDA receptor subtype, phencyclidine, psychiatric disorders.
Current Molecular Medicine
Title:Specific Roles of NMDA Receptor Subunits in Mental Disorders
Volume: 15 Issue: 3
Author(s): H. Yamamoto, Y. Hagino, S. Kasai and K. Ikeda
Affiliation:
- Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science, 2-1-6 Kamikitazawa, Setagaya-ku, Tokyo 156-8506, Japan.,Japan
Keywords: GluN1, GluN2D, knockout mice, NMDA receptor subtype, phencyclidine, psychiatric disorders.
Abstract: N-methyl-D-aspartate (NMDA) receptor plays important roles in learning and memory. NMDA receptors are a tetramer that consists of two glycine-binding subunits GluN1, two glutamate-binding subunits (i.e., GluN2A, GluN2B, GluN2C, and GluN2D), a combination of a GluN2 subunit and glycine-binding GluN3 subunit (i.e., GluN3A or GluN3B), or two GluN3 subunits. Recent studies revealed that the specific expression and distribution of each subunit are deeply involved in neural excitability, plasticity, and synaptic deficits. The present article summarizes reports on the dysfunction of NMDA receptors and responsible subunits in various neurological and psychiatric disorders, including schizophrenia, autoimmune-induced glutamatergic receptor dysfunction, mood disorders, and autism. A key role for the GluN2D subunit in NMDA receptor antagonist-induced psychosis has been recently revealed.
Export Options
About this article
Cite this article as:
Yamamoto H., Hagino Y., Kasai S. and Ikeda K., Specific Roles of NMDA Receptor Subunits in Mental Disorders, Current Molecular Medicine 2015; 15(3) . https://dx.doi.org/10.2174/1566524015666150330142807
DOI https://dx.doi.org/10.2174/1566524015666150330142807 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |

- Author Guidelines
- Editorial Policies
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Allegations from Whistleblowers
- Publishing Ethics and Rectitude
- Increase Visibility Of Your Article
- Archiving Policies
- Reviewer Guidelines
- Guest Editor Guidelines
- Board Recruitment Workflow
- Short Guide
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Inflammation and Immunology of the Vitreoretinal Compartment
Inflammation & Allergy - Drug Targets (Discontinued) An Update of the Review of Neuropsychological Consequences of HIV and Substance Abuse: A Literature Review and Implications for Treatment and Future Research
Current Drug Abuse Reviews Reverse Vaccinology: An Epitope Based Approach to Design Vaccines
Current Bioinformatics Behcets Syndrome: Literature Review
Current Rheumatology Reviews Prevalence of Toxoplasma Encephalitis in AIDS Patients Treated with Didanosine Hospitalised in a French Infectious Service
Current HIV Research The Causes and Consequences of Childhood Encephalitis in Asia
Infectious Disorders - Drug Targets REM Sleep Behavior Disorder and Narcolepsy
CNS & Neurological Disorders - Drug Targets Immunobiology of Herpes Simplex Virus and Cytomegalovirus Infections of the Fetus and Newborn
Current Immunology Reviews (Discontinued) The Use of the Inhibitory Receptors for Modulating the Immune Responses
Current Pharmaceutical Design Anti-Inflammatory Activity of Tetracyclines: Applications to Human Disease
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Collateral Damage: Contribution of Peripheral Inflammation to Neurodegenerative Diseases
Current Topics in Medicinal Chemistry Astrocyte Signaling and Multiple Sclerosis
Current Signal Transduction Therapy Development and Applications of Non-HIV-Based Lentiviral Vectors in Neurological Disorders
Current Gene Therapy Control of Autoimmune Diseases by the B7-CD28 Family Molecules
Current Pharmaceutical Design Anti-NMDA Receptor Encephalitis in a Patient with a History of Autism Spectrum Disorder
Adolescent Psychiatry Immunopotentiation for Bacterial Biodefense
Current Topics in Medicinal Chemistry Neurotrophic Actions of Mood-Stabilizers: A Recent Research Discovery and its Potential Clinical Applications
Current Psychiatry Reviews Virus Attachment and Entry Offer Numerous Targets for Antiviral Therapy
Current Pharmaceutical Design From Test Tube to Clinical Trial; Promising Herbs with NF-κB and COX- 2 Activity
Current Immunology Reviews (Discontinued) Inhibition of Viral-Induced Membrane Fusion by Peptides
Protein & Peptide Letters